Naseptin Nasal Cream

Naseptin® Nasal Cream (neomycin sulphate, chlorhexidine dihydrochloride) – Formulation Update

Naseptin® Nasal Cream (neomycin sulphate, chlorhexidine dihydrochloride) underwent a formulation change in 2023, the excipient Arachis oil (peanut oil) was removed.

The last batches of the original formulation containing Arachis oil expired on 31st October 2025. As of 1st November 2025, we expect that only the revised formulation without Arachis oil remains on the market. There should no longer be any batches of the original formulation of Naseptin® Nasal Cream containing Arachis oil in the supply chain.

There are no listed contraindications regarding patients with peanut or soya allergy for Naseptin Nasal Cream. Nonetheless, Healthcare professionals should continue to review patient allergy status, in line with the approved Product Information as part of routine prescribing and dispensing practices.

For further information, please contact the Medical Information department at Alliance Pharmaceuticals Ltd: call +44 (0)1249 466 966 or email [email protected].